Review: Risk stratification in the hormonal treatment of patients with prostate cancer
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review: Risk stratification in the hormonal treatment of patients with prostate cancer
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 1, Issue 2, Pages 79-94
Publisher
SAGE Publications
Online
2009-08-19
DOI
10.1177/1758834009340164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zoledronic acid in the management of metastatic bone disease
- (2016) Thomas Polascik Therapeutics and Clinical Risk Management
- Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy
- (2009) Toni K. Choueiri et al. CANCER
- A 16-year clinical experience with intermittent androgen deprivation for prostate cancer: oncological results
- (2009) Dominique Prapotnich et al. WORLD JOURNAL OF UROLOGY
- Maximal androgen blockade for advanced prostate cancer
- (2008) Laurence Klotz BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer
- (2008) Christopher J. DiBlasio et al. BJU INTERNATIONAL
- Metabolic and cardiovascular effects of androgen deprivation therapy
- (2008) Payam Hakimian et al. BJU INTERNATIONAL
- The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
- (2008) Laurence Klotz et al. BJU INTERNATIONAL
- Management of Complications of Prostate Cancer Treatment
- (2008) M. D. Michaelson et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer
- (2008) Robert W. Ross et al. CANCER
- Cognitive effects of hormone therapy in men with prostate cancer
- (2008) Christian J. Nelson et al. CANCER
- Body composition changes during androgen deprivation therapy for prostate cancer: A 2-year prospective study
- (2008) Gijsberta J. van Londen et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Continuous versus Six Months a Year Maximal Androgen Blockade in the Management of Prostate Cancer: A Randomised Study
- (2008) Jacques Irani et al. EUROPEAN UROLOGY
- Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks
- (2008) Hendrik Isbarn et al. EUROPEAN UROLOGY
- Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
- (2008) Jason A. Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Timing of Androgen Deprivation Therapy and its Impact on Survival After Radical Prostatectomy: A Matched Cohort Study
- (2008) Sameer A. Siddiqui et al. JOURNAL OF UROLOGY
- Increased Risk of Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2008) Polly E Kintzel et al. PHARMACOTHERAPY
- Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality
- (2008) Christine S. Chung et al. UROLOGY
- Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)
- (2007) Urs E. Studer et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer
- (2007) Axel Heidenreich et al. EUROPEAN UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now